News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Acorda Therapeutics Elects Barry Greene, COO Of (Alnylam Pharmaceuticals To Its Board Of Directors
January 8, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc® (Nasdaq: ACOR) today announced that Barry Greene, Chief Operating Officer of Alnylam Pharmaceuticals (Nasdaq: ALNY), has been elected to its Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
Alnylam Pharmaceuticals
MORE ON THIS TOPIC
Earnings
Gilead’s PrEP Launch Full Speed Ahead Despite Macro Pressures on HIV Space
April 25, 2025
·
3 min read
·
Tristan Manalac
Earnings
BMS Reports Mixed Earnings as Growth Portfolio Makes Up for Generic Pressure
April 24, 2025
·
2 min read
·
Dan Samorodnitsky
Earnings
Tariff Uncertainty Reigns Over Q1 Earnings, With Merck Taking $200M Blow So Far
April 24, 2025
·
3 min read
·
Annalee Armstrong
Startups
Novartis-, Sanofi-Backed Granite Brings $100M to Compete in Crowded I&I Space
April 24, 2025
·
2 min read
·
Tristan Manalac